Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 2/20 | 0.62 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.62 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.62 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CPA1 | P15085 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.38 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.38 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | HTR2B | P41595 | 1/20 | 0.38 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2412183 | 0.88 | RNPEP (0.55) | SLC1A3SLC1A2SLC1A1RNPEPSLC7A5 | |
| SCHEMBL9677603 | 0.87 | SLC1A3 (0.56) | SLC1A3SLC1A2SLC1A1RNPEPSLC7A5 | |
| SCHEMBL9676557 | 0.85 | SLC1A3 (0.54) | SLC1A3SLC1A2SLC1A1RNPEPSLC7A5 | |
| SCHEMBL9675609 | 0.85 | SLC1A3 (0.54) | SLC1A3SLC1A2SLC1A1RNPEPSLC7A5 | |
| SCHEMBL9675574 | 0.85 | SLC1A3 (0.54) | SLC1A3SLC1A2SLC1A1RNPEPSLC7A5 | |
| SCHEMBL9675622 | 0.85 | SLC1A3 (0.54) | SLC1A3SLC1A2SLC1A1RNPEPSLC7A5 | |
| SCHEMBL6870066 | 0.83 | SLC1A3 (0.62) | SLC1A3SLC1A2SLC1A1RNPEPSLC7A5 | |
| SCHEMBL7384828 | 0.82 | SLC1A3 (0.45) | SLC1A3SLC1A2SLC1A1RNPEPSLC7A5 | |
| SCHEMBL2921465 | 0.82 | SLC1A3 (0.45) | SLC1A3SLC1A2SLC1A1RNPEPSLC7A5 | |
| SCHEMBL7453161 | 0.81 | RNPEP (0.48) | SLC1A3SLC1A2SLC1A1RNPEPSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3088955-B1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHINETSU CHEMICAL CO (JP) | 2020-06-03 | — | — | EP | claimed |
| EP-3202876-B1 | FIXED BED DECOLORIZATION PROCESS FOR UNSATURATED FATTY ACID | ZHEJIANG MED XINCHANG PHARM (CN) | 2019-07-31 | — | — | EP | claimed |
| EP-3032333-B1 | SHRINK MATERIAL AND PATTERN FORMING PROCESS | SHINETSU CHEMICAL CO (JP) | 2017-05-24 | — | — | EP | claimed |
| EP-3032332-B1 | SHRINK MATERIAL AND PATTERN FORMING PROCESS | SHINETSU CHEMICAL CO (JP) | 2017-04-05 | — | — | EP | claimed |
| EP-1853713-B1 | Process for the isolation of polyhydroxyalkanoates (PHAs) from bacterial cells by solvent extraction | PHB IND SA (BR) | 2012-05-02 | — | — | EP | claimed |
| EP-3839028-B1 | CLEANING PRODUCT | PROCTER & GAMBLE (US) | 2025-01-15 | — | — | EP | disclosed |
| EP-4386075-A2 | CLEANING PRODUCT | The Procter & Gamble Company (US) | 2024-06-19 | — | — | EP | disclosed |
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2024-04-04 | — | — | US | disclosed |
| US-11834627-B2 | Cleaning product | THE PROCTER & GAMBLE COMPANY (US) | 2023-12-05 | — | — | US | disclosed |
| US-11834629-B2 | Cleaning product | THE PROCTER & GAMBLE COMPANY (US) | 2023-12-05 | — | — | US | disclosed |
| EP-4124651-B1 | CLEANING PRODUCT | PROCTER & GAMBLE (US) | 2023-11-29 | — | — | EP | disclosed |
| US-11779013-B2 | Stabilized peroxyacid solutions | EVONIK CORPORATION (US) | 2023-10-10 | — | — | US | disclosed |
| US-20130225649-A1 | COMPOUNDS FROM ANTRODIA CINNAMOMEA AND USE THEREOF | SIMPSON BIOTECH CO., LTD. (TW) | 2013-08-29 | — | — | US | disclosed |
| US-20130045165-A1 | 4-FLUORO-4-ARYLPIPERDIN-1-YL DERIVATIVES AS MU OPIOID FUNCTION MODERATORS | KINENTIA BIOSCIENCES, LLC (US) | 2013-02-21 | — | — | US | disclosed |
| US-8367666-B2 | 3-carbamoyl-2-pyridone derivatives | SHIONOGI & CO., LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| US-8367666-B2 | 3-carbamoyl-2-pyridone derivatives | SHIONOGI & CO., LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| US-8178681-B2 | methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency | SHIONOGI & CO., LTD. (JP) | 2012-05-15 | — | — | US | disclosed |
| US-8178681-B2 | methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency | SHIONOGI & CO., LTD. (JP) | 2012-05-15 | — | — | US | disclosed |
| US-20110230350-A1 | ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS | BAYER CROPSCIENCE AG (DE) | 2011-09-22 | — | — | US | disclosed |
| US-20110230350-A1 | ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS | BAYER CROPSCIENCE AG (DE) | 2011-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | TAS2R40, TAS2R60, TAS1R1 | SLC1A3 480/4885SLC1A2 412/4885SLC1A1 502/4885 |
| US-20130225649-A1 | COMPOUNDS FROM ANTRODIA CINNAMOMEA AND USE THEREOF | HAVCR2, CYP51A1, NPC1 | SLC1A3 2657/4885SLC1A2 3693/4885SLC1A1 3281/4885 |
| US-20110230350-A1 | ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS | STS, ARSA, TST | SLC1A3 4334/4885SLC1A2 3431/4885SLC1A1 3793/4885 |
| US-11779013-B2 | Stabilized peroxyacid solutions | PGD, ACMSD, ALAD | SLC1A3 3310/4885SLC1A2 4001/4885SLC1A1 3695/4885 |
| US-20130045165-A1 | 4-FLUORO-4-ARYLPIPERDIN-1-YL DERIVATIVES AS MU OPIOID FUNCTION MODERATORS | OPRD1, OPRK1, OPRM1 | SLC1A3 2205/4885SLC1A2 1305/4885SLC1A1 663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.